MediciNova
MNOV
60 hedge funds and large institutions have $59.4M invested in MediciNova in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
12% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 17
5% more funds holding
Funds holding: 57 → 60 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $59.5M → $59.4M (-$146K)
1.03% less ownership
Funds ownership: 25.25% → 24.21% (-1%)
16% less call options, than puts
Call options by funds: $443K | Put options by funds: $527K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
| 2 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
+$832K |
| 3 |
JP Morgan Chase
New York
|
+$829K |
| 4 |
Jane Street
New York
|
+$591K |
| 5 |
BlackRock
New York
|
+$428K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Greenlight Capital
New York
|
-$974K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$471K |
| 3 |
Renaissance Technologies
New York
|
-$274K |
| 4 |
State Street
Boston,
Massachusetts
|
-$259K |
| 5 |
Millennium Management
New York
|
-$207K |
MNOV Hedge Fund Activity: Q1 2021 in Review
60 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2021, worth a combined $59.4M — down 0.25% from $59.5M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MNOV positions and 8 closed out — a net gain of 3 holders — while 19 added to existing stakes and 17 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.18M. The largest seller was Greenlight Capital, exiting entirely with an estimated $974K sold.
- 60 institutional investors held MediciNova (MNOV) as of Q1 2021, up from 57 in Q4 2020.
- Funds reported $59.4M of MediciNova stock for Q1 2021, down 0.25% quarter-over-quarter.
- 11 funds opened new MediciNova positions in Q1 2021 and 8 closed out, a net change of +3 holders.
- The largest MediciNova buyer in Q1 2021 was Vanguard Group, an estimated $1.18M added.
- The largest MediciNova seller in Q1 2021 was Greenlight Capital, an estimated $974K sold.
Based on aggregated 13F filings for Q1 2021.